Emma is a fully qualified European patent attorney with over 20 years’ experience in the pharmaceutical industry.

Previously Emma was IP Director at Jazz Pharmaceuticals, having joined Jazz on the acquisition of GW Pharmaceuticals plc.

At GW Emma was responsible for generating the patent portfolios for Epidiolex® and Sativex® in addition to IP-related activities such as trade mark filing, brand protection, licensing, and regulatory data protection activities.